| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
39 |
| Employees |
- |
| Revenues (TTM) (Millions $) |
17 |
| Net Income (TTM) (Millions $) |
-106 |
| Cash Flow (TTM) (Millions $) |
0 |
| Capital Exp. (TTM) (Millions $) |
12 |
Business Description
Isoplexis Corporation is a biotechnology company that specializes in innovative solutions for single-cell analysis. The company develops technologies and products for the analysis of immune cell function and biomarker discovery in the field of immunology. Isoplexis Corporation's products enable researchers to analyze and understand the functional heterogeneity of immune cells, allowing for more precise and targeted therapies for diseases such as cancer, autoimmune disorders, and infectious diseases. The company's flagship product, the IsoPlexis platform, provides high-throughput and sensitive analysis of functional immune profiles at the single-cell level, enabling researchers to gain insights that were previously unattainable. Isoplexis Corporation is dedicated to advancing the field of single-cell biology and improving patient outcomes through their innovative technologies.
Company Address: 35 NE Industrial Road Branford 6405 CT
Company Phone Number: 208-4111 Stock Exchange / Ticker: NASDAQ ISO
|
%